NCT01929356 Chest Physiotherapy and Lung Function in Primary Ciliary Dyskinesia
| NCT ID | NCT01929356 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Primary Ciliary Dyskinesia |
| Study Type | INTERVENTIONAL |
| Enrollment | 29 participants |
| Start Date | 2020-06-30 |
| Primary Completion | 2025-11 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Primary ciliary dyskinesia (PCD) is a rare disease, caused by impairment of the motile cilia. Patients present with chronic upper and lower respiratory tract infections. The therapy is mainly supportive and based on that of cystic fibrosis. Chest physiotherapy is one of the cornerstones of the therapy, however the influence of chest physiotherapy on lung function (short term and long term) is not clear. For interpretation of longitudinal lung function data it is important to examine the short time effect of chest physiotherapy. We hypothesize that a session of chest physiotherapy improves lung function and that thus lung function tests must be performed in a standardized way.
Eligibility Criteria
Inclusion Criteria: * Primary ciliary dyskinesia * able to perform spirometry and MBW (\>6 years) Exclusion Criteria: * acute exacerbation